Kent and Medway
Joint Medicines Formulary
NHS Kent and Medway
  • Therapeutic Sections
    • Gastro-intestinal system
    • Cardiovascular system
    • Respiratory system
    • Nervous system
    • Infection
    • Endocrine system
    • Genito-urinary system
    • Immune system and malignant disease
    • Blood and Nutrition
    • Musculoskeletal system
    • Eye
    • Ear, nose and oropharynx
    • Skin
    • Vaccines
    • Anaesthesia
    • Preparations used in diagnosis
    • Emergency treatment of poisoning
    • Wound Management
    • Over the Counter Items
  • K&M ICB Guidelines
    • KMICB - Antimicrobial Guidelines
    • KMICB - Gastro-intestinal system
    • KMICB - Cardiovascular system
    • KMICB - Respiratory system
    • KMICB - Nervous system
    • KMICB - Endocrine system
    • KMICB - Genito-urinary system
    • KMICB - Immune system and malignant disease
    • KMICB - Blood and nutrition
    • KMICB - Musculoskeletal system
    • KMICB - Eye
    • KMICB - Ear, nose and oropharynx
    • KMICB - Skin
    • KMICB - Vaccines
    • KMICB - Shared Care Guidance
    • KMICB - Palliative Care
    • KMICB - Miscellaneous
    • KMICB - Communications
    • KMICB - Stoma Products
    • KMICB - Continence products
    • KMICB - Care Home Resources
    • High Cost Drugs Manual
    • SERMOG Recommendations
  • Maidstone and Tunbridge Wells NHS Trust (MTW)
    • MTW - Antimicrobial Guidelines
    • MTW - Electrolyte Guidelines
    • MTW - Thromboembolism Guidelines
    • MTW - Miscellaneous Guidelines
    • MTW - Drug Request Forms & Procedures
  • Dartford and Gravesham NHS Trust (DGT)
  • Medway Foundation Trust NHS Trust (MFT)
  • East Kent Primary Care and East Kent Hospitals University NHS Foundation Trust (EKHUFT)
    • EK - Local recommendations (Cardiovascular)
    • EK - Local recommendations (Eye)
    • EK - Local recommendations (Gastro-intestinal)
    • EK - Local recommendations (Nose)
    • EK - Local recommendations (Nutrition)
    • EK - Local recommendations (Oropharynx)
    • EK - Local recommendations (Respiratory)
    • EK - Local recommendations (Blood)
    • EK - Local recommendations (Nervous system)
    • EK - Local recommendations (Infection)
    • EK - Local recommendations (Endocrine)
    • EK - Local recommendations (Genito-urinary)
    • EK - Local recommendations (Malignant disease)
    • EK - Local recommendations (Musculoskeletal system)
    • EK - Local recommendations (Skin)
    • EK - Local recommendations (Vaccines)
    • EK - Prescribing Recommendations
  • Using the Formulary
  • Therapeutic Sections
  • K&M ICB Guidelines
  • K&M ICB Medicine Applications
  • K&M ICB Primary Care Newsletters
  • K&M ICB Integrated Medicines Optimisation Commitee (IMOC) Minutes
  • Maidstone and Tunbridge Wells NHS Trust (MTW)
  • Dartford and Gravesham NHS Trust (DGT)
  • Medway Foundation Trust NHS Trust (MFT)
  • East Kent Primary Care and East Kent Hospitals University NHS Foundation Trust (EKHUFT)
  • Intravenous Immunoglobulin (IVIG)
  • Drug Index
  • Search

Drug Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

R

  • Raloxifene

    Go to the EMC website for more information and guidance.
  • Ramipril

    Go to the EMC website for more information and guidance.
  • Ranibizumab

    Ophthalmology Initiation High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ranolazine

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rasagiline

    Go to the EMC website for more information and guidance.
  • Rasburicase

    High Cost Drug Go to the EMC website for more information and guidance.
  • Ravulizumab

    Prescribe by Brand High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Relugolix

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Relugolix + estradiol + norethisterone acetate (Ryeqo)

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Remifentanil

    Controlled Drug Go to the EMC website for more information and guidance.
  • Repaglinide

    Go to the EMC website for more information and guidance.
  • Resource ThickenUp Clear

    Go to the EMC website for more information and guidance.
  • Respiratory syncytial virus vaccine

  • Retlecitinib (Litfulo)

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ribavirin

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rifabutin

    Go to the EMC website for more information and guidance.
  • Rifampicin

    Go to the EMC website for more information and guidance.
  • Rifampicin (Tuberculosis)

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rifampicin + Isoniazid (Rifinah)

    Go to the EMC website for more information and guidance.
  • Rifampicin + Isoniazid + Pyrazinamide (Rifater)

    Go to the EMC website for more information and guidance.
  • Rifampicin + Isoniazid + Pyrazinamide + Ethambutol (Voractiv)

    Go to the EMC website for more information and guidance.
  • Rifaximin

    Shared Care Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Riluzole

    Shared Care Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rimegepant (preventative)

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Rimegepant (treatment)

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Risankizumab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Risankizumab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Risankizumab (Skyrizi)

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Risedronate sodium

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Risperidone

    Go to the EMC website for more information and guidance.
  • Ritlecitinib

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Rituximab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rituximab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Rivaroxaban

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rivastigmine

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rizatriptan

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rocuronium

    Go to the EMC website for more information and guidance.
  • Roflumilast

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Romiplostim

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Romosozumab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ropeginterferon alfa-2b (Besremi)

    High Cost Drug Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Ropinirole

    Go to the EMC website for more information and guidance.
  • Ropivacaine

    Go to the EMC website for more information and guidance.
  • Rosuvastatin

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Rotavirus vaccine

    Go to the EMC website for more information and guidance.
  • Rotigotine

    Go to the EMC website for more information and guidance.
  • Roxadustat

    Dartford and Gravesham NHS Trust ONLY East Kent Hospital University Foundation Trust ONLY High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026